SANOFICONRBSESANOFI CONS HEALTHC IND LHighNeutral
Announced Wed, 28 Oct, 2026 · 18:40 IST

Third-quarter revenue rises 12% and profit before tax rises 22%

Ebitda Margin ExpansionExceptional ItemResults View source PDFExplain this filing

SANOFICONR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

September 2026 quarter revenue was Rs 2,631 million, up 12% year on year, with domestic sales up 19%. Profit before tax rose 22% to Rs 1,027 million and earnings per share reached Rs 33.26. Nine-month revenue rose 16% to Rs 7,280 million and net profit rose 23% to Rs 2,132 million. Prior-year results included a Rs 66 million one-off provision reversal; product recalls also affect comparisons. The limited review found no material issue.

Likely market impact

Strong revenue and profit growth and wider margins are positive for shareholders, though product recalls limit direct prior-year comparisons.